Chele Chiavacci Farley's Insider Trades & SAST Disclosures

Chele Chiavacci Farley's most recent trade in Conduit Pharmaceuticals Inc was a trade of 35,000 Common Stock done . Disclosure was reported to the exchange on Aug. 5, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Conduit Pharmaceuticals Inc
Chele Chiavacci Farley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2025 35,000 37,369 - 0 Common Stock
Conduit Pharmaceuticals Inc
Chele Chiavacci Farley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2025 15,000 15,000 - - Stock Option (Right to Buy)
Conduit Pharmaceuticals Inc
Chele Chiavacci Farley Director Grant, award, or other acquisition of securities at price $ 0.89 per share. 30 Mar 2025 32,022 35,537 - 0.9 28,500 Common Stock
Conduit Pharmaceuticals Inc
Chiavacci Chele Farley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2024 420,000 420,000 - - Stock Option (Right to Buy)
Conduit Pharmaceuticals Inc
Chele Chiavacci Farley Director Grant, award, or other acquisition of securities at price $ 0.09 per share. 18 Nov 2024 299,238 351,510 - 0.1 27,500 Common Stock
Conduit Pharmaceuticals Inc
Chele Chiavacci Farley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 37,272 52,272 - - Common Stock
Conduit Pharmaceuticals Inc
Chele Chiavacci Farley Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Apr 2024 200,332 203,332 - - Warrant (Right to buy)
Conduit Pharmaceuticals Inc
Chele Chiavacci Farley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Apr 2024 3,000 3,000 - - Warrant (Right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades